Avadel Pharmaceuticals Plc - Company Profile
Powered by
All the data and insights you need on Avadel Pharmaceuticals Plc in one report.
- Save hours of research time and resources with
our up-to-date Avadel Pharmaceuticals Plc Strategy Report
- Understand Avadel Pharmaceuticals Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (narcolepsy), pain, respiratory diseases and diabetes. It’s products are built on its proprietary polymer-based technologies: Micropump, an oral sustained release microparticles platform, LiquiTime, a Micropump – derived platform for liquid oral products, and Medusa that enables controlled release of injectables. It sells products in the US and Ireland. The company operates in St. Louis, Missouri and Charlotte in the US. Avadel is headquartered in Dublin, Ireland.
Avadel Pharmaceuticals Plc premium industry data and analytics
Products and Services
Products |
---|
Pipeline Product: |
FT218 (excessive daytime sleepiness and cataplexy in adults with narcolepsy) |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Regulatory Approval | In May, the company announced the approval and grant of orphan drug status for LUMRYZ. |
2023 | Contracts/Agreements | In March, the company entered into an agreement with RTW Investments to acquire royalty for US$75 million. |
2022 | Others | In November, the company announced favorable ruling on its motion to delist REMS patent from FDA’s Orange Book. |
Competitor Comparison
Key Parameters | Avadel Pharmaceuticals Plc | Albireo Pharma Inc | Elite Pharmaceuticals Inc | DURECT Corp | Acura Pharmaceuticals Inc |
---|---|---|---|---|---|
Headquarters | Ireland | United States of America | United States of America | United States of America | United States of America |
City | Dublin | Boston | Northvale | Cupertino | Palatine |
State/Province | - | Massachusetts | New Jersey | California | Illinois |
No. of Employees | 154 | 130 | 53 | 72 | 14 |
Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Geoffrey M. Glass | Chairman | Executive Board | 2018 | 49 |
Gregory J. Divis | Chief Executive Officer; Director | Executive Board | 2019 | 56 |
Thomas S. McHugh | Chief Financial Officer | Senior Management | 2019 | 58 |
Richard Kim | Chief Commercial Officer | Senior Management | 2021 | 53 |
Jerad G. Seurer | General Counsel; Corporate Secretary | Senior Management | 2017 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward